Labtec starts Sufentanil transdermal patch Phase II trial
Sufentanil TDS is a matrix-type transdermal patch with the active ingredient sufentanil, a highly potent opioid analgesic that is used as an injection or infusion for anesthesia and
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
Major players profiled in the report titled ‘Specialty Enzymes: A Global Strategic Business Report’ include Advanced Enzymes Technologies, Amano Enzyme, Aureozyme, Biocon, Biozyme Laboratories, Codexis, Danisco, Genencor International,